{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:45Z","timestamp":1790741985708,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Low-energy extracorporeal shock waves (LESW) have been studied as a new treatment for angina pectoris and several ischemic diseases because of its effect on angiogenesis and inhibition of fibrosis of the heart. The effect of LESW on fibrosis in liver cirrhosis has not been studied. The aim of this study was to verify the amelioration of liver fibrosis by LESW and elucidate its mechanisms in a rat model of drug-induced liver cirrhosis. Male Wistar rats aged 7 weeks were injected with carbon tetrachloride intraperitoneally twice a week for 12 weeks. Eight rats underwent LESW therapy (0.25 mJ\/mm<jats:sup>2<\/jats:sup>, 4\u2009Hz, 1000 shots) under general anesthesia (shock wave group). Seven rats only underwent general anesthesia (control group). Quantitative analysis showed that the area of fibrosis in the shock wave group was significantly reduced compared with the control group (11,899.9 vs. 23,525.3 pixels per field, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In the shock wave group, the mRNA expression of transforming growth factor (TGF)-\u03b21 was significantly suppressed (0.40-fold, <jats:italic>p<\/jats:italic>\u2009=\u20090.018) and vascular endothelial growth factor-B was significantly increased (1.77-fold, <jats:italic>p<\/jats:italic>\u2009=\u20090.006) compared with the control group. Serum albumin was significantly higher in the shock wave group than in the control group (3.0 vs. 2.4\u2009g\/dl, <jats:italic>p<\/jats:italic>\u2009=\u20090.025). Aspartate aminotransferase\/alanine aminotransferase ratio decreased by LESW compared with the control group (1.49 vs. 2.04, <jats:italic>p<\/jats:italic>\u2009=\u20090.013). These results suggest that LESW therapy ameliorates liver fibrosis by reducing the expression of TGF-\u03b21 and increasing the expression of angiogenic factors, and improves hepatic function.<\/jats:p>","DOI":"10.1038\/s41598-020-58369-w","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T11:03:58Z","timestamp":1581505438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Low-energy extracorporeal shock wave therapy for a model of liver cirrhosis ameliorates liver fibrosis and liver function"],"prefix":"10.1038","volume":"10","author":[{"given":"Naoto","family":"Ujiie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"58369_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00535-009-0128-5","volume":"45","author":"K Michitaka","year":"2010","unstructured":"Michitaka, K. et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J. Gastroenterol. 45, 86\u201394 (2010).","journal-title":"J. Gastroenterol."},{"key":"58369_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Invest. 115, 209\u2013218 (2005).","journal-title":"J. Clin. Invest."},{"key":"58369_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.219.1","volume":"219","author":"K Ito","year":"2009","unstructured":"Ito, K., Fukumoto, Y. & Shimokawa, H. Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. Tohoku J. Exp. Med. 219, 1\u20139 (2009).","journal-title":"Tohoku J. Exp. Med."},{"key":"58369_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1253\/circj.CJ-09-1028","volume":"74","author":"Y Kikuchi","year":"2010","unstructured":"Kikuchi, Y. et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ. J. 74, 589\u2013591 (2010).","journal-title":"Circ. J."},{"key":"58369_CR5","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1253\/circj.CJ-11-1216","volume":"76","author":"F Serizawa","year":"2012","unstructured":"Serizawa, F. et al. Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication. Circ. J. 76, 1486\u20131493 (2012).","journal-title":"Circ. J."},{"key":"58369_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/11592760-000000000-00000","volume":"11","author":"K Ito","year":"2011","unstructured":"Ito, K., Fukumoto, Y. & Shimokawa, H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. Am. J. Cardiovasc. Drugs. 11, 295\u2013302 (2011).","journal-title":"Am. J. Cardiovasc. Drugs."},{"key":"58369_CR7","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1253\/circj.CJ-14-0230","volume":"78","author":"Y Abe","year":"2014","unstructured":"Abe, Y. et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ. J. 78, 2915\u20132925 (2014).","journal-title":"Circ. J."},{"key":"58369_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1620\/tjem.221.151","volume":"221","author":"C Nakanishi","year":"2010","unstructured":"Nakanishi, C., Doi, H., Katsura, K. & Satomi, S. Treatment with L-valine ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to carbon tetrachloride. Tohoku J. Exp. Med. 221, 151\u2013159 (2010).","journal-title":"Tohoku J. Exp. Med."},{"key":"58369_CR9","doi-asserted-by":"publisher","first-page":"33750","DOI":"10.1074\/jbc.273.50.33750","volume":"273","author":"Y Kim","year":"1998","unstructured":"Kim, Y. et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9\/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J. Biol. Chem. 273, 33750\u201333758 (1998).","journal-title":"J. Biol. Chem."},{"key":"58369_CR10","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1073\/pnas.83.12.4167","volume":"83","author":"AB Roberts","year":"1986","unstructured":"Roberts, A. B. et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167\u20134171 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58369_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1152\/ajpcell.00328.2012","volume":"304","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg, M. & Kalluri, R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am. J. Physiol. Cell Physiol. 304, 216\u2013225 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"58369_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2741\/A812","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner, A. M., Weiskirchen, R., Breitkopf, K. & Dooley, S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, 793\u2013807 (2002).","journal-title":"Front. Biosci."},{"key":"58369_CR13","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00595-010-4484-9","volume":"41","author":"D Yoshida","year":"2011","unstructured":"Yoshida, D. et al. Roles of vascular endothelial growth factor and endothelial nitric oxide synthase during revascularization and regeneration after partial hepatectomy in a rat model. Surg. Today. 41, 1622\u20131629 (2011).","journal-title":"Surg. Today."},{"key":"58369_CR14","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1074\/jbc.M308013200","volume":"279","author":"FS Wang","year":"2004","unstructured":"Wang, F. S. et al. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J. Biol. Chem. 279, 10331\u201310337 (2004).","journal-title":"J. Biol. Chem."},{"key":"58369_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/325257a0","volume":"325","author":"L Schweigerer","year":"1987","unstructured":"Schweigerer, L. et al. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature. 325, 257\u2013259 (1987).","journal-title":"Nature."},{"key":"58369_CR16","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman, J. & Shing, Y. Angiogenesis. J. Biol. Chem. 267, 10931\u201310934 (1992).","journal-title":"J. Biol. Chem."},{"key":"58369_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jacc.2010.01.070","volume":"56","author":"SW Kim","year":"2010","unstructured":"Kim, S. W. et al. Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J. Am. Coll. Cardiol. 56, 593\u2013607 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58369_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.surg.2009.10.015","volume":"147","author":"AB Dogrul","year":"2010","unstructured":"Dogrul, A. B. et al. Antiangiogenic response after 70% hepatectomy and its relationship with hepatic regeneration and angiogenesis in rats. Surgery. 147, 288\u2013294 (2010).","journal-title":"Surgery."},{"key":"58369_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1267\/ahc.14030","volume":"47","author":"S Takekoshi","year":"2014","unstructured":"Takekoshi, S., Kitatani, K. & Yamamoto, Y. Roles of Oxidized Diacylglycerol for Carbon Tetrachloride-induced Liver Injury and Fibrosis in Mouse. Acta Histochem. Cytochem. 47, 185\u2013194 (2014).","journal-title":"Acta Histochem. Cytochem."},{"key":"58369_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1248\/bpb.33.983","volume":"33","author":"A Itoh","year":"2010","unstructured":"Itoh, A. et al. Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol. Pharm. Bull. 33, 983\u2013987 (2010).","journal-title":"Biol. Pharm. Bull."},{"key":"58369_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","volume":"93","author":"SG Sheth","year":"1998","unstructured":"Sheth, S. G., Flamm, S. L., Gordon, F. D. & Chopra, S. AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44\u201348 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"58369_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.22913","volume":"50","author":"R Jalan","year":"2009","unstructured":"Jalan, R. et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 50, 555\u2013564 (2009).","journal-title":"Hepatology."},{"key":"58369_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","volume":"8","author":"C Valerio","year":"2016","unstructured":"Valerio, C., Theocharidou, E., Davenport, A. & Agarwal, B. Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion. World J. Hepatol. 8, 345\u2013354 (2016).","journal-title":"World J. Hepatol."},{"key":"58369_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2003.07.016","volume":"313","author":"H Moriwaki","year":"2004","unstructured":"Moriwaki, H. et al. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem. Biophys. Res. Commun. 313, 405\u2013409 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58369_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3748\/wjg.v12.i13.2053","volume":"12","author":"H Makino","year":"2006","unstructured":"Makino, H. et al. Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. World J. Gastroenterol. 12, 2053\u20132059 (2006).","journal-title":"World J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58369-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58369-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:46:12Z","timestamp":1670309172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58369-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58369-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2405"}}